Document is current
Any future updates will be listed below
-
Authors
Escalante-Pérez, Iván A.
Alviares, Ana A.
Omaña-Ávila, Óscar D.
Carrión-Nessi, Fhabián S.
Mendoza-Millán, Daniela L.
Erimee-Vieira, Grecia de J.
Contreras-Rengifo, Juan M.
Sande-Mujica, Vanessa C.
de Marchis-Vento, Mariana de J.
Gebran-Chedid, Karim J.
Dubuc-Ponte, Mario A.
Castro-Betancourt, Daniela I.
Fuentes-Fiore, Vittoria F.
Molina-Mendoza, Rachell A.
Loreto-Rodrigues, Alejandro M.
Gomes-González, Juan C.
Mauriello, Luciano
Moronta, Eyleen
Alarcón de Noya, Belkisyolé
Díaz-Bello, Zoraida
Forero-Peña, David A.
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 14 May 2025
First Online: 8 June 2025
Declarations
:
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (1975, revised 2013) for research involving human subjects. The protocol was reviewed and approved by the Independent Bioethics Committee for Research of the National Center for Bioethics (CIBI-CENABI, in Spanish) of Venezuela (CIBI-CENABI-16/2023). Prior to participation, all subjects received detailed information about the study objectives and procedures, including blood sample collection, and provided both written and verbal informed consent. For participants under 18 years of age, informed consent was obtained from their parents and/or authorized representatives. All patients who tested positive for T. cruzi antibodies were evaluated by specialists at the Instituto de Medicina Tropical "Dr. Félix Pifano" and received therapeutic recommendations on the basis of established international guidelines [].
: Not applicable.
: The authors declare no competing interests.
